Ruben Mesa: Extremely fortunate to have Marissa Howard-Mcnatt for Breast Cancer at Atrium Health Levine Cancer Institute
Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute, reshared a post by Wake Forest University School of Medicine on LinkedIn, adding:
“We are extremely fortunate to have Marissa Howard-Mcnatt as one our key leaders for Breast Cancer at Atrium Health Levine Cancer and Atrium Health Wake Forest Baptist Comprehensive Cancer Center.”
Wake Forest University School of Medicine shared a post on LinkedIn:
“2024 Wrapped meet Marissa Howard-McNatt, MD, one of less than 20 African-American female surgeons with full professorships in the U.S.
As a professor of surgical sciences – oncology, she’s breaking barriers and inspiring future generations.
From her all-girls undergrad to Harvard Medical School, she merged her passions for women’s health, surgery, and oncology to become a surgical breast oncologist.
Now, she leads the Breast Care Center and co-leads the breast solid tumors board at Atrium Health Wake Forest Baptist’s NCI-designated Comprehensive Cancer Center.
When not in the OR, she’s advancing patient care through research on breast neoplasms, disparity research, genetic testing, and more.
Her work on the SHAVE Study and the I-SPY trial is groundbreaking.
Marissa is proud to be a professor of surgery and hopes to inspire young researchers.
Her advice?
Listen to your patients and collaborate with colleagues.
Oh, and she’s also a wife, mother of three, and a musician.”
Dr. Ruben Mesa, MD, FACP, serves as the President and Executive Director of Atrium Health Levine Cancer Institute (LCI) and Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Additionally, he holds the position of vice dean for cancer programs and professor of medicine at Wake Forest University School of Medicine.
He is an international expert in hematologic cancers, particularly myeloproliferative neoplasms (MPNs). Through his tireless efforts, Dr. Mesa continues to drive progress in the understanding and treatment of hematologic malignancies, offering hope to those affected by these complex diseases.
More posts featuring Wake Forest University School of Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023